Equivocal Radiotracer Uptake on 18F-PSMA-1007 PET/CT in Patients with Prostate Cancer

被引：0
|
作者：
Spurr, M. [1 ]
Kimura, M. [1 ]
Kulshresthra, R. [1 ]
Kabala, J. [1 ]
Challapalli, A. [1 ]
Sakthithasan, M. [1 ]
机构：
[1] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England
来源：
INTERNAL MEDICINE JOURNAL | 2022年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P32
引用
收藏
页码：41 / 42
页数：2
相关论文
共 50 条
  • [1] Skeletal 18F-PSMA-1007 uptake in prostate cancer patients
    Janssen, Jorinde
    Noordzij, Walter
    Velleman, Ton
    de Jong, Igle Jan
    Langendijk, Johannes A.
    Verzijlbergen, J. Fred
    Stormezand, Gilles N.
    Aluwini, Shafak
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [2] Non-prostate uptake on 18F-PSMA-1007 PET/CT: a case of myeloma
    Veerasuri, Sowmya
    Redman, Stewart
    Graham, Richard
    Meehan, Chris
    Little, David
    BJR CASE REPORTS, 2021, 7 (02):
  • [3] Atypical neoplastic solitary focal uptake of 18F-PSMA-1007 in PET/CT in patients with biochemically recurrent prostate cancer
    Antonevskaya, T. L.
    Khalimon, A. I.
    Khodzhibekova, M. M.
    Atakishieva, L. U.
    Khamadeeva, G. F.
    Khodakova, D. Yu.
    Lazutina, T. N.
    Pylova, I. V.
    Volchenko, N. N.
    Leontyev, A. V.
    ONKOUROLOGIYA, 2023, 19 (04): : 131 - 138
  • [4] Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
    Rahbar, Kambiz
    Afshar-Oromieh, Ali
    Seifert, Robert
    Wagner, Stefan
    Schaefers, Michael
    Boegemann, Martin
    Weckesser, Matthias
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 (12) : 2055 - 2061
  • [5] Diagnostic performance of 18F-PSMA-1007 PET/CT in patients with biochemical recurrent prostate cancer
    Kambiz Rahbar
    Ali Afshar-Oromieh
    Robert Seifert
    Stefan Wagner
    Michael Schäfers
    Martin Bögemann
    Matthias Weckesser
    European Journal of Nuclear Medicine and Molecular Imaging, 2018, 45 : 2055 - 2061
  • [6] Reciprocal metabolism of 18F-PSMA-1007 and 18F-FDG PET/CT in patients with prostate cancer at staging
    Kim, J.
    Lee, S.
    Kim, D.
    Kim, H.
    Kim, S.
    Ko, H.
    Kim, S.
    Kim, W.
    Choi, Y.
    Giesel, F.
    Lee, M.
    Cho, N.
    Yun, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S403 - S403
  • [7] Comparison of the 18F-PSMA-1007 and 18F-FAPI-42 PET/ CT in the evaluation of prostate cancer and correlation between PSMA and FAPI uptake
    Mu, X.
    Li, M.
    Fu, W.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S536 - S536
  • [8] Biokinetics and dosimetry of 18F-PSMA-1007 in patients with prostate cancer
    Hvittfeldt, Erland
    Bjoersdorff, Mimmi
    Brolin, Gustav
    Minarik, David
    Svegborn, Sigrid L.
    Oddstig, Jenny
    Tragardh, Elin
    CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, 2022, 42 (06) : 443 - 452
  • [9] Increased Uptake of 18F-PSMA-1007 in Corpus Luteum Demonstrated by PET/CT
    Geysen, Astrid
    Goffin, Karolien
    Van Weehaeghe, Donatienne
    Van Laere, Koen
    Deroose, Christophe M.
    CLINICAL NUCLEAR MEDICINE, 2022, 47 (03) : E331 - E332
  • [10] Impact of 18F-PSMA-1007 Ligand PET/CT in Multimodal Imaging of Recurrent Prostate Cancer
    Dronka, L.
    Radzina, M.
    Tirane, M.
    Zemniece, L.
    Kalnina, M.
    Roznere, L.
    Lietuvietis, V.
    Freimanis, A.
    Vjaters, E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S27 - S28
12345